Back to Search
Start Over
A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle
- Source :
- Journal of Nutritional Science, Hoggard, N, Cruickshank, M, Moar, K-M, Bestwick, C, Holst, J J, Russell, W & Horgan, G 2013, ' A single supplement of a standardised bilberry ( Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle ', Journal of Nutritional Science, vol. 2, e22 . https://doi.org/10.1017/jns.2013.16
- Publication Year :
- 2013
- Publisher :
- Cambridge University Press, 2013.
-
Abstract
- Dietary strategies for alleviating health complications associated with type 2 diabetes (T2D) are being pursued as alternatives to pharmaceutical interventions. Berries such as bilberries (Vaccinium myrtillus L.) that are rich in polyphenols may influence carbohydrate digestion and absorption and thus postprandial glycaemia. In addition, berries have been reported to alter incretins as well as to have antioxidant and anti-inflammatory properties that may also affect postprandial glycaemia. The present study investigated the acute effect of a standardised bilberry extract on glucose metabolism in T2D. Male volunteers with T2D (n 8; BMI 30 (sd 4) kg/m2) controlling their diabetes by diet and lifestyle alone were given a single oral capsule of either 0·47 g standardised bilberry extract (36 % (w/w) anthocyanins) which equates to about 50 g of fresh bilberries or placebo followed by a polysaccharide drink (equivalent to 75 g glucose) in a double-blinded cross-over intervention with a 2-week washout period. The ingestion of the bilberry extract resulted in a significant decrease in the incremental AUC for both glucose (P = 0·003) and insulin (P = 0·03) compared with the placebo. There was no change in the gut (glucagon-like peptide-1, gastric inhibitory polypeptide), pancreatic (glucagon, amylin) or anti-inflammatory (monocyte chemotactic protein-1) peptides. In addition there was no change in the antioxidant (Trolox equivalent antioxidant capacity, ferric-reducing ability of plasma) responses measured between the volunteers receiving the bilberry extract and the placebo. In conclusion the present study demonstrates for the first time that the ingestion of a concentrated bilberry extract reduces postprandial glycaemia and insulin in volunteers with T2D. The most likely mechanism for the lower glycaemic response involves reduced rates of carbohydrate digestion and/or absorption.
- Subjects :
- Bilberry
Endocrinology, Diabetes and Metabolism
medicine.medical_treatment
OGTT, oral glucose tolerance test
Trolox equivalent antioxidant capacity
Blood sugar
T2D, type 2 diabetes
Type 2 diabetes
Pharmacology
Bilberries
Glycaemic response
Vaccinium myrtillus
Anthocyanins
FRAP, ferric-reducing ability of plasma
Medicine
TEAC, Trolox equivalent antioxidant capacity
Nutrition and Dietetics
biology
business.industry
Insulin
GIP, gastric inhibitory polypeptide
GLP-1, glucagon-like peptide-1
medicine.disease
biology.organism_classification
Nutritional Endocrinology
Ferric reducing ability of plasma
MCP-1, monocyte chemotactic protein-1
Postprandial
Biochemistry
AUCi, incremental AUC
business
Food Science
Subjects
Details
- Language :
- English
- ISSN :
- 20486790
- Volume :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of Nutritional Science
- Accession number :
- edsair.doi.dedup.....45f15bc544c1d1ca74d412c7b49de90e
- Full Text :
- https://doi.org/10.1017/jns.2013.16